The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
| Metrics | Current | 2024 | 2023 | 2022 | 
|---|---|---|---|---|
| 
										
										Value
									 | 55 | 43 | 54 | 63 | 
| 
										
										Growth
									 | 75 | 13 | 77 | 51 | 
| 
										
										Safety
									 | 18 | 51 | 70 | 19 | 
| 
										
										Sentiment
									 | 45 | 13 | 82 | 63 | 
| 
										
										360° View
									 | 43 | 9 | 93 | 35 | 
| Metrics | Current | 2024 | 2023 | 2022 | 
|---|---|---|---|---|
| 
										Analyst Opinions
									 | 87 | 100 | 100 | 100 | 
| 
										Opinions Change
									 | 50 | 50 | 50 | 50 | 
| 
										Pro Holdings
									 | n/a | 1 | 31 | 57 | 
| 
										Market Pulse
									 | 20 | 24 | 51 | 52 | 
| 
										
										Sentiment
									 | 45 | 13 | 82 | 63 | 
| Metrics | Current | 2024 | 2023 | 2022 | 
|---|---|---|---|---|
| 
										
										Value
									 | 55 | 43 | 54 | 63 | 
| 
										
										Growth
									 | 75 | 13 | 77 | 51 | 
|  | 18 | 51 | 70 | 19 | 
| 
										
										Combined
									 | 38 | 11 | 93 | 96 | 
| Metrics | Current | 2024 | 2023 | 2022 | 
|---|---|---|---|---|
| 
										Price vs. Sales (P/S)
									 | 50 | 50 | 50 | 50 | 
| 
										Price vs. Earnings (P/E)
									 | 47 | 88 | 73 | 75 | 
| 
										Price vs. Book (P/B)
									 | 96 | 24 | 57 | 80 | 
| 
										Dividend Yield
									 | 1 | 1 | 1 | 1 | 
| 
										
										Value
									 | 55 | 43 | 54 | 63 | 
| Metrics | Current | 2024 | 2023 | 2022 | 
|---|---|---|---|---|
| 
										Revenue Growth
									 | 88 | 93 | 85 | 82 | 
| 
										Profit Growth
									 | 39 | 1 | 10 | 14 | 
| 
										Capital Growth
									 | 20 | 4 | 95 | 75 | 
| 
										Stock Returns
									 | 100 | 11 | 81 | 31 | 
| 
										
										Growth
									 | 75 | 13 | 77 | 51 | 
| Metrics | Current | 2024 | 2023 | 2022 | 
|---|---|---|---|---|
| 
										Leverage
									 | 14 | 27 | 58 | 62 | 
| 
										Refinancing
									 | 60 | 98 | 96 | 28 | 
| 
										Liquidity
									 | 4 | 11 | 17 | 6 | 
|  | 18 | 51 | 70 | 19 | 
Discover high‑ranked alternatives to The Oncology Institute and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.
30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.